Georgia woman indicates she suffered vision loss from Ezricare Artificial Tears eye drops purchased at Walmart in 2022, which were recalled months later due to bacterial contamination.
Final approval of the $2 million Fabuloso class action settlement is expected in April 2024, providing financial compensation for consumers who paid premium prices for contaminated cleaning products.
Lawsuit indicates that recalled Artificial Tears eye drops caused an infection, which left the plaintiff legally blind in both eyes.
Lawsuit indicates EzriCare eye drop infection occurred months after an Artificial Tears recall over Pseudomonas aeruginosa contamination.
Lawsuit alleges contaminated eye drops caused a Pseudomonas aeruginosa infection and antibiotics did little to help fight off the treatment-resistant bacterial contamination
As a result of the Fabuloso infection risk, class action lawsuit seeks more than $5 million for consumers who paid a premium price for the recalled cleaning products
Florida woman had to undergo eye surgery after normal treatments failed to work agains a Pseudomonas Aeruginosa eye drops infection
